237 filings
15-12G
CCXI
ChemoCentryx Inc
31 Oct 22
Securities registration termination
6:06am
S-8 POS
CCXI
ChemoCentryx Inc
20 Oct 22
Registration of securities for employees (post-effective amendment)
9:28am
S-8 POS
CCXI
ChemoCentryx Inc
20 Oct 22
Registration of securities for employees (post-effective amendment)
9:27am
POSASR
CCXI
ChemoCentryx Inc
20 Oct 22
Automatic shelf registration (post-effective amendment)
9:26am
8-K
CCXI
ChemoCentryx Inc
20 Oct 22
Amgen Successfully Completes Acquisition of Chemocentryx
9:20am
25-NSE
2khajo6qkj4m
20 Oct 22
Exchange delisting
8:40am
8-K
eq2ny hucm
18 Oct 22
Submission of Matters to a Vote of Security Holders
4:16pm
DEFA14A
t5oy3 17sqd
7 Oct 22
Additional proxy soliciting materials
4:35pm
DEFA14A
8aodafuh7f3v
19 Sep 22
Additional proxy soliciting materials
9:26pm
8-K
w7bc9nqx8ig 690
19 Sep 22
Other Events
9:23pm
DEFM14A
kdmt3xqedu40iu3zx1hp
14 Sep 22
Proxy related to merger
5:31pm
PREM14A
b7rf38 ov47
31 Aug 22
Preliminary proxy related to merger
5:07pm
DEFA14A
pav8l2uyde izoryei0a
30 Aug 22
Additional proxy soliciting materials
6:25pm
DEFA14A
ru1f26y
22 Aug 22
Additional proxy soliciting materials
9:28pm
DEFA14A
xh8d5o42n6ud
9 Aug 22
Additional proxy soliciting materials
12:00am
DEFA14A
l7bt6q9z
8 Aug 22
Additional proxy soliciting materials
8:00am
8-K
uft9jh9fw0sm
4 Aug 22
Amgen to Acquire Chemocentryx for $4 Billion In Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine
8:16am
8-K
pqm2rgr3rftwf
5 Jul 22
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
8:48am
8-K
vupwcb1d
9 Jun 22
Departure of Directors or Certain Officers
4:40pm